# FDA recall D-1850-2019

> **Pacifico National, Inc. dba AmEx Pharmacy** · Class II · drug recall initiated 2019-08-30.

## Product

Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901

## Reason for recall

Lack of assurance of sterility.

## Distribution

Continental U.S. and Puerto Rico

## Key facts

- **Recall number:** D-1850-2019
- **Recalling firm:** Pacifico National, Inc. dba AmEx Pharmacy
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-08-30
- **Report date:** 2019-09-18
- **Termination date:** 2020-10-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Melbourne, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1850-2019

## Citation

> AI Analytics. FDA recall D-1850-2019. Retrieved 2026-06-04 from https://api.ai-analytics.org/recall/D-1850-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*